> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# ICU Medical Earns $26.8 Million As Infusion Sales Grow And Margins Widen
- URL: https://www.bullished.co/icu-medical-earns-26-8-million-as-infusion-sales-grow-and-margins-widen-4e3fcc87/
- Published: 2026-11-06T14:27:28.000Z
- Updated: 2026-11-06T14:27:28.000Z
- Description: The medical-products maker kept its 2026 forecast intact but expects results toward the higher end of its ranges.
- Author: Matteo Parrino
- Tags: SEC Filings, ICUI, Industry: Healthcare

[ICU Medical](https://www.bullished.co/tag/icui/), which makes infusion and critical-care products, earned [$26.8 million](https://finance.yahoo.com/healthcare/articles/icu-medical-q3-earnings-snapshot-224135250.html?ref=bullished.co) in the third quarter, reversing a year-earlier loss of $3.4 million, according to results furnished with its Thursday [SEC filing](https://www.sec.gov/Archives/edgar/data/0000883984/000088398426000049/icui-20261105.htm?ref=bullished.co). Sales increased and gross margins widened, while management left its annual forecast unchanged and said it expects results toward the higher end of its ranges.

## More Profit From Growing Sales

Revenue reached $560.4 million, compared with $537.0 million a year earlier. The company's [earnings release](https://www.sec.gov/Archives/edgar/data/0000883984/000088398426000049/exhibit991q32026er.htm?ref=bullished.co) put growth at 4% as reported and 5% after excluding currency changes, divestitures and certain contract-manufacturing sales.

Gross profit—the revenue remaining after product costs—was [$234.8 million](https://www.globenewswire.com/news-release/2026/11/05/3397067/0/en/icu-medical-announces-third-quarter-2026-results-and-reaffirms-fiscal-year-2026-guidance-expecting-results-at-the-high-end-of-range.html?ref=bullished.co), against $200.9 million a year earlier. Gross margin reached 42%, compared with 37%.

Diluted earnings were [$1.07 per share](https://finance.yahoo.com/healthcare/articles/icu-medical-q3-earnings-snapshot-224135250.html?ref=bullished.co), against a loss of $0.14\. On the company's adjusted measure, earnings increased to $2.44 per share from $2.03, while adjusted earnings before interest, taxes, depreciation and amortization reached $113.9 million, versus $105.9 million.

The improvement included lower restructuring, transaction and integration expenses: $6.271 million, versus $13.138 million. Net interest expense also fell, to $15.240 million from $19.808 million. The adjusted results excluded tariff refunds, along with items such as stock pay, amortization and product-remediation costs.

## Infusion Outpaces Vital Care

Infusion Systems generated $192.5 million in sales, versus $173.9 million a year earlier. Vivek Jain, ICU Medical's chief executive officer, said results were "[ahead of our expectations](https://www.sec.gov/Archives/edgar/data/0000883984/000088398426000049/exhibit991q32026er.htm?ref=bullished.co) for Infusion Systems" and that the rest of the business generally met expectations.

Consumables remained the largest product line, with revenue of [$298.4 million](https://www.globenewswire.com/news-release/2026/11/05/3397067/0/en/icu-medical-announces-third-quarter-2026-results-and-reaffirms-fiscal-year-2026-guidance-expecting-results-at-the-high-end-of-range.html?ref=bullished.co), compared with $285.1 million. Vital Care moved in the opposite direction, recording $69.5 million against $78.0 million.

ICU Medical supplies hospitals, clinics and home-care providers with products including IV pumps, connectors, catheters and respiratory equipment. Its business also includes selling IV solutions for a joint venture in which it owns a 40% interest.

The company [sold IV Solutions](https://www.sec.gov/Archives/edgar/data/0000883984/000088398426000049/exhibit991q32026er.htm?ref=bullished.co) on May 1, 2025\. That operation had been part of Vital Care and supplied $127.4 million of revenue, including contract manufacturing, during the first nine months of 2025\. For the first nine months of 2026, total revenue fell 3% as reported, while growth excluding currency effects, divestitures and certain contract-manufacturing sales was 4%.

## Cash Builds, Forecast Stays Intact

Third-quarter free cash flow reached $83,417,000, compared with $27,630,000 a year earlier. ICU Medical defines that measure as operating cash flow minus property and equipment purchases, plus proceeds from asset sales; it does not deduct debt-service payments or other obligations.

Operating cash flow for the quarter was $99.586 million, versus $56.710 million. Property and equipment purchases declined to $16.186 million from $29.080 million.

Management continues to forecast 2026 net income of $73 million–$83 million and diluted earnings of $2.89–$3.29 per share. Its adjusted ranges remain $8.60–$9.00 per share and $415 million–$435 million for earnings before interest, taxes, depreciation and amortization.

The stronger quarter changed management's expected position within those ranges—toward the higher end—rather than the forecasts themselves.

Learn

- [Item 2.02: results of operations →](https://www.bullished.co/learn/8-k-items-explained/#item-202-results-of-operations)  
From 8-K Items Explained: What Every Item Code From 1.01 To 9.01 Tells You, With Examples

### Sources

- [8-K Filing — ICU MEDICAL INC/DE (ICUI)](https://www.sec.gov/Archives/edgar/data/0000883984/000088398426000049/icui-20261105.htm?ref=bullished.co) — SEC EDGAR
- [Exhibit exhibit991q32026er.htm — ICU MEDICAL INC/DE 8-K exhibit](https://www.sec.gov/Archives/edgar/data/0000883984/000088398426000049/exhibit991q32026er.htm?ref=bullished.co) — SEC EDGAR
- [ICU Medical (ICUI) Beats Q3 Earnings and Revenue Estimates](https://finance.yahoo.com/healthcare/articles/icu-medical-icui-beats-q3-000013372.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [ICU Medical (ICUI) Reports Q3 Earnings: What Key Metrics Have to Say](https://finance.yahoo.com/markets/stocks/articles/icu-medical-icui-reports-q3-233002888.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [ICU Medical: Q3 Earnings Snapshot](https://finance.yahoo.com/healthcare/articles/icu-medical-q3-earnings-snapshot-224135250.html?ref=bullished.co) — Associated Press
- [ICU Medical (ICUI) Q3 2026 Earnings Call Transcript - The Globe and Mail](https://www.theglobeandmail.com/investing/markets/markets-news/Motley%20Fool/8693352/icu-medical-icui-q3-2026-earnings-call-transcript/?ref=bullished.co) — theglobeandmail.com
- [ICU Medical Announces Third Quarter 2026 Results and](https://www.globenewswire.com/news-release/2026/11/05/3397067/0/en/icu-medical-announces-third-quarter-2026-results-and-reaffirms-fiscal-year-2026-guidance-expecting-results-at-the-high-end-of-range.html?ref=bullished.co) — globenewswire.com

### More on ICU Medical

- [ICU Medical Hits Its Debt Target After Repaying $80 Million, Eyes Shifting 'Value From Debt To Equity'](https://www.bullished.co/icu-medical-hits-its-debt-target-after-repaying-80-million-eyes-shifting-value-from-debt-7bf1169c/)

[All ICU Medical (ICUI) coverage →](https://www.bullished.co/tag/icui/)